Relmada Therapeutics logo

Relmada Therapeutics

RLMD | NASDAQ
Chart Builder DCF Calculator
$3.61
-$0.60 (-14.25%)
At close: Nov 16, 2026, 4:00 PM ET
$3.61
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-14.25%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #607/1021 (Top 59%)

Key Statistics

Market Data

Market Cap $405.9M
1D Range
3.46 4.13
52W Range
3.10 7.86

Valuation (TTM)

PE -4.88
PB 2.10
EV/EBITDA -3.14

Valuation (NTM)

Forward PE N/A
Forward PEG 0.12
Price Target $12.00
Loading financial charts...

Profile

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of g...

Sector Healthcare
Industry Biotechnology
Employees 17
IPO Date Jun 20, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$12.00
Upside
+232.41%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.